Malcolm Mizzi is taking on a new position within gambling software provider and slot studio Nolimit City as chief operating officer.

Having served at the company for the past five years, Mr Mizzi has occupied a variety of senior roles. He currently also serves as Commercial Director and has served as CCO and managing director.

The company has also appointed James Davies to the role of head of client management. He has been engaged with Nolimit City for almost three years, and has been promoted from the role of senior client account manager.

Nolimit City is an international company, based in Malta, Sweden and India and is known for its unique and sometimes controversial slot titles.

Back in June the company made headlines after it was announced that gambling giant Evolution, also based in Malta, struck a deal to acquire the slot studio for up to €340 million.





Continue Reading

Just Slots secures MGA licence as Head of Client Strategy hails ‘significant growth’ opportunity

29 September 2026
by Julia Falzon

Malta-based Just Slots secures MGA Licence and Partners with Hub88 for Game Distribution


White Hat Gaming appoints Leon Thomas as Chief Commercial Officer

29 September 2026
by Julia Falzon

He brings with him over 20 years of experience in the global gaming industry

MGA suspends Condor Malta Limited’s gaming licence

28 September 2026
by Julia Falzon

The company is no longer authorised to carry out any gaming operations, but it is required to provide access to all registered players to their player accounts

Betano preparing legal action to protect its rights in Brazil, major iGaming operator says

28 September 2026
by Kevin Schembri Orland

Company says that while Brazil is Betano’s largest market, the business benefits from a broad international footprint

EuroMillions operator fined €60,000 for ‘serious and systemic’ breaches of anti-money laundering rules

28 September 2026
by Julia Falzon

The FIAU identified shortcomings in the company's customer risk assessments, customer profiling, transaction monitoring and PEP screening

See more